Nonantibiotic topicals effectively treat without contributing to drug resistance

Article

New agents, as well as other available nonantibiotic topical agents, can be helpful in successful wound healing, says Leon H. Kircik, M.D., clinical associate professor of dermatology, Indiana University, and medical director, DurhamResearch, PLC, in Louisville, KY.

Related Videos
Related Content

Oxidative Damage Induces Increase of Pro-Inflammatory IL-15 in Vitiligo

October 4th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Addressing Disparities in Atopic Dermatitis Education on TikTok

October 4th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Real-World Insights: Systemic Therapies in Moderate to Severe Atopic Dermatitis Patients

October 3rd 2023

Larry Eichenfield, MD, Addresses Pediatric AD, Upcoming Therapies, and Misinformation From Social Media

October 3rd 2023

Oxidative Damage Induces Increase of Pro-Inflammatory IL-15 in Vitiligo

October 4th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Addressing Disparities in Atopic Dermatitis Education on TikTok

October 4th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Real-World Insights: Systemic Therapies in Moderate to Severe Atopic Dermatitis Patients

October 3rd 2023

Larry Eichenfield, MD, Addresses Pediatric AD, Upcoming Therapies, and Misinformation From Social Media

October 3rd 2023

Oxidative Damage Induces Increase of Pro-Inflammatory IL-15 in Vitiligo

October 4th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Addressing Disparities in Atopic Dermatitis Education on TikTok

October 4th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Real-World Insights: Systemic Therapies in Moderate to Severe Atopic Dermatitis Patients

October 3rd 2023

Larry Eichenfield, MD, Addresses Pediatric AD, Upcoming Therapies, and Misinformation From Social Media

October 3rd 2023
© 2023 MJH Life Sciences

All rights reserved.